Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

Recruiting now

Conditions studied: Colorectal Cancer

In brief

The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.

Key facts

Study ID

NCT05234177

Run by

Tempus AI

People needed

300

Starts

2022-06-21

Expected to finish

2029-02-01

Last updated by the study team

2025-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Known or suspected colorectal adenocarcinoma (Stage I to IVA disease)
• Planning to undergo or has undergone a surgical resection for suspected adenocarcinoma of the colon or rectum with curative intent.
• 18 years old or older
• Willing and able to provide informed consent
• Willing to have additional blood samples collected during routine surveillance visits

You may not qualify if…

• Not willing to have additional blood samples collected
• Pathology that is not consistent with colorectal adenocarcinoma

Where it is running

• Mercy Clinic Oncology - Fort Smith — Fort Smith, Arkansas, United States (enrolling)
• MemorialCare — Fountain Valley, California, United States (enrolling)
• The Center for Cancer and Blood Disorders — Bethesda, Maryland, United States (enrolling)
• Mercy Clinic Oncology and Hematology - Joplin — Joplin, Missouri, United States (enrolling)
• Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center — Springfield, Missouri, United States (enrolling)
• Washington University School of Medicine — St Louis, Missouri, United States (enrolling)
• Mercy Clinic Oncology and Hematology - Sindelar Cancer Center — St Louis, Missouri, United States (enrolling)
• Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center — St Louis, Missouri, United States (enrolling)
• Nebraska Cancer Specialists — Omaha, Nebraska, United States (enrolling)
• Southeastern Medical Oncology Center — Goldsboro, North Carolina, United States (enrolling)
• Aultman Hospital — Canton, Ohio, United States (enrolling)
• TriHealth Cancer Institute — Cincinnati, Ohio, United States (enrolling)
• Ohio State University — Columbus, Ohio, United States (enrolling)
• OhioHealth Research Institute — Columbus, Ohio, United States (enrolling)
• Toledo Clinic Cancer Center — Toledo, Ohio, United States (enrolling)
• Mercy Clinic Oncology and Hematology - Coletta — Oklahoma City, Oklahoma, United States (enrolling)
• Cancer Care Associates of York — York, Pennsylvania, United States (enrolling)
• Utah Cancer Specialists — Salt Lake City, Utah, United States (enrolling)
• University of Washington / Fred Hutchinson Cancer Center — Seattle, Washington, United States (enrolling)
• ThedaCare Regional Cancer Center — Appleton, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.